Matthew L Sherman - Net Worth and Insider Trading
Matthew L Sherman Net Worth
The estimated net worth of Matthew L Sherman is at least $16 Million dollars as of 2024-11-10. Matthew L Sherman is the EVP & Chief Medical Officer of Acceleron Pharma Inc and owns about 77,267 shares of Acceleron Pharma Inc (XLRN) stock worth over $14 Million. Matthew L Sherman is also the EVP & Chief Medical Officer of Deciphera Pharmaceuticals Inc and owns about 94,079 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $2 Million. Details can be seen in Matthew L Sherman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew L Sherman has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew L Sherman
Matthew L Sherman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew L Sherman owns 5 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Pieris Pharmaceuticals Inc (PIRS) , and Lumos Pharma Inc (LUMO) among others .
Click here to see the complete history of Matthew L Sherman’s form 4 insider trades.
Insider Ownership Summary of Matthew L Sherman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | EVP & Chief Medical Officer |
| PIRS | Pieris Pharmaceuticals Inc | 2023-06-21 | director |
| LUMO | Lumos Pharma Inc | 2018-04-27 | director |
 | | 2016-09-29 | director |
| | 2018-04-03 | EVP & Chief Medical Officer |
Matthew L Sherman Latest Holdings Summary
Matthew L Sherman currently owns a total of 2 stocks. Among these stocks, Matthew L Sherman owns 77,267 shares of Acceleron Pharma Inc (XLRN) as of April 3, 2018, with a value of $14 Million and a weighting of 85.16%. Matthew L Sherman also owns 94,079 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 16, 2024, with a value of $2 Million and a weighting of 14.84%.
Latest Holdings of Matthew L Sherman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XLRN | Acceleron Pharma Inc | 2018-04-03 | 77,267 | 178.75 | 13,811,476 |
| DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | 94,079 | 25.59 | 2,407,482 |
Holding Weightings of Matthew L Sherman
Matthew L Sherman Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew L Sherman has made a total of 0 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years. The most-recent trade in Acceleron Pharma Inc is the sale of 4,600 shares on April 3, 2018, which brought Matthew L Sherman around $176,778.
According to the SEC Form 4 filings, Matthew L Sherman has made a total of 11 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 2,435 shares on January 16, 2024, which brought Matthew L Sherman around $35,234.
Insider Trading History of Matthew L Sherman
- 1
Matthew L Sherman Trading Performance
Matthew L Sherman Ownership Network
Ownership Network List of Matthew L Sherman
Ownership Network Relation of Matthew L Sherman
Matthew L Sherman Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Matthew L Sherman is the EVP & Chief Medical Officer of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include Chief Financial Officer Thomas Patrick Kelly , Chief Commercial Officer Daniel C. Martin , and SVP & Regulatory & Quality Jama Pitman .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Matthew L Sherman made 5 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 12,184. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 9,198 shares made by Thomas Patrick Kelly , and a net sale of 5,931 shares made by Jama Pitman .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Matthew L Sherman Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew L Sherman. You might contact Matthew L Sherman via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
